Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 51, 2016 - Issue 5
Submit an article Journal homepage
820
Views
34
CrossRef citations to date
0
Altmetric
Original Article

Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure

Vendel KristensenDepartment of Medicine, Unger-Vetlesen’s Institute, Lovisenberg Diaconal Hospital, Oslo, Norway; ;Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Correspondence[email protected]
,
Gunn Helen MalmstrømDepartment of Medicine, Unger-Vetlesen’s Institute, Lovisenberg Diaconal Hospital, Oslo, Norway;
,
Viggo SkarDepartment of Medicine, Unger-Vetlesen’s Institute, Lovisenberg Diaconal Hospital, Oslo, Norway;
,
Arne RøsethDepartment of Medicine, Section of Gastroenterology, Lovisenberg Diaconal Hospital, Oslo, Norway;
&
Bjørn MoumInstitute of Clinical Medicine, University of Oslo, Oslo, Norway; ;Department of Gastroenterology, Oslo University Hospital, Oslo, Norway
Pages 548-555 | Received 11 Jun 2015, Accepted 03 Nov 2015, Published online: 04 Dec 2015

Citations (34)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

R. Gacesa, A. Vich Vila, V. Collij, Z. Mujagic, A. Kurilshikov, M.D. Voskuil, E.A.M. Festen, C. Wijmenga, D.M.A.E. Jonkers, G. Dijkstra, J. Fu, A. Zhernakova, F. Imhann & R.K. Weersma. (2021) A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease. Gut Microbes 13:1.
Read now
Kaija-Leena Kolho & Henrik Alfthan. (2020) Concentration of fecal calprotectin in 11,255 children aged 0–18 years. Scandinavian Journal of Gastroenterology 55:9, pages 1024-1027.
Read now
Amanda Ricciuto & Anne M. Griffiths. (2019) Clinical value of fecal calprotectin. Critical Reviews in Clinical Laboratory Sciences 56:5, pages 307-320.
Read now
Takayuki Yamamoto & Takahiro Shimoyama. (2017) Monitoring and detection of disease recurrence after resection for Crohn’s disease: the role of non-invasive fecal biomarkers. Expert Review of Gastroenterology & Hepatology 11:10, pages 899-909.
Read now
Paula Ministro & Diana Martins. (2017) Fecal biomarkers in inflammatory bowel disease: how, when and why?. Expert Review of Gastroenterology & Hepatology 11:4, pages 317-328.
Read now
Kaija-Leena Kolho. (2016) Assessment of disease activity in pediatric ulcerative colitis. Expert Review of Gastroenterology & Hepatology 10:10, pages 1127-1134.
Read now

Articles from other publishers (28)

Jennifer Murray, Klaartje B Kok & Ruth M Ayling. (2023) Fecal Calprotectin in Gastrointestinal Disease. Clinical Chemistry 69:7, pages 699-710.
Crossref
Lies E J L Dijkhuis, Femke Crouwel, Marjolijn Duijvestein, Hans J C Buiter, Nanne K de Boer & Henrike M Hamer. (2023) The Reliability of Patient-Performed Fecal Calprotectin Testing in Inflammatory Bowel Disease. The Journal of Applied Laboratory Medicine 8:2, pages 319-329.
Crossref
Siddharth Singh, Ashwin N. Ananthakrishnan, Nghia H. Nguyen, Benjamin L. Cohen, Fernando S. Velayos, Jennifer M. Weiss, Shahnaz Sultan, Shazia M. Siddique, Jeremy Adler & Karen A. Chachu. (2023) AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis. Gastroenterology 164:3, pages 344-372.
Crossref
Nikolas Plevris & Charlie W. Lees. (2022) Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities. Gastroenterology 162:5, pages 1456-1475.e1.
Crossref
Leo Lin, Sara P Wyness, Ryan Jensen, Joseph Bird, Tenzin Norgyal, Gabrielle Jensen & Lisa M Johnson. (2022) Comparison of Next-Generation Assays for Fecal Calprotectin vs the PhiCal Assay. American Journal of Clinical Pathology 157:2, pages 252-256.
Crossref
S. Nancey, B. Flourié, C. Gay & G. Boschetti. (2021) What dermatologists should know about faecal calprotectin to allow adequate interpretation of the results in clinical practice. Clinical and Experimental Dermatology 46:4, pages 742-743.
Crossref
Ferdinando D'Amico, David T. Rubin, Paulo Gustavo Kotze, Fernando Magro, Britta Siegmund, Taku Kobayashi, Pablo A. Olivera, Peter Bossuyt, Lieven Pouillon, Edouard Louis, Eugeni Domènech, Subrata Ghosh, Silvio Danese & Laurent Peyrin‐Biroulet. (2021) International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases. United European Gastroenterology Journal 9:4, pages 451-460.
Crossref
Carmen Ribes Koninckx, Ester Donat, Marc A. Benninga, Ilse J. Broekaert, Frederic Gottrand, Kaija-Leena Kolho, Paolo Lionetti, Erasmo Miele, Rok Orel, Alexandra Papadopoulou, Corina Pienar, Michela G. Schäppi, Michael Wilschanski & Nikhil Thapar. (2021) The Use of Fecal Calprotectin Testing in Paediatric Disorders: A Position Paper of the European Society for Paediatric Gastroenterology and Nutrition Gastroenterology Committee. Journal of Pediatric Gastroenterology & Nutrition 72:4, pages 617-640.
Crossref
Ferdinando D’Amico, Stéphane Nancey, Silvio Danese & Laurent Peyrin-Biroulet. (2021) A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities. Journal of Crohn's and Colitis 15:1, pages 152-161.
Crossref
Friederike CordesClaudia DemmigArne BokemeyerMarkus BrücknerFrank LenzePhilipp LenzTobias NowackiPhil TepasseHartmut H. SchmidtM. Alexander SchmidtChristoph CichonDominik Bettenworth. (2020) MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease. Clinical and Translational Gastroenterology 11:3, pages e00134.
Crossref
Rasmus Goll, Richard Heitmann, Øystein Kittel Moe, Katrine Carlsen & Jon Florholmen. (2019) Head to head comparison of two commercial fecal calprotectin kits as predictor of Mayo endoscopic sub-score and mucosal TNF expression in ulcerative colitis. PLOS ONE 14:12, pages e0224895.
Crossref
Anneline Cremer, Jade Ku, Leila Amininejad, Marie-Rose Bouvry, Fabian Brohet, Claire Liefferinckx, Jacques Devière, André van Gossum, Julie Smet, Patrick Stordeur & Denis Franchimont. (2019) Variability of Faecal Calprotectin in Inflammatory Bowel Disease Patients: An Observational Case-control Study. Journal of Crohn's and Colitis 13:11, pages 1372-1379.
Crossref
Parambir S. Dulai, Laurent Peyrin-Biroulet, Silvio Danese, Bruce E. Sands, Axel Dignass, Dan Turner, Gerassimos Mantzaris, Juergen Schölmerich, Jean-Yves Mary, Walter Reinisch & William J. Sandborn. (2019) Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases. Gastroenterology 157:4, pages 1032-1043.e1.
Crossref
Emilio J. Laserna-Mendieta & Alfredo J. Lucendo. (2019) Faecal calprotectin in inflammatory bowel diseases: a review focused on meta-analyses and routine usage limitations. Clinical Chemistry and Laboratory Medicine (CCLM) 57:9, pages 1295-1307.
Crossref
Tereza Lerchova, Ondrej Hradsky, Ivana Copova, Kristyna Potuznikova, Lucie Gonsorcikova & Jiri Bronsky. (2019) The Accuracy of a Home-performed Faecal Calprotectin Test in Paediatric Patients With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 69:1, pages 75-81.
Crossref
Honghui Zhou & Diane R. MouldReena Khanna & Brian G. Feagan. 2019. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases 25 42 .
David T. Rubin, Ashwin N. Ananthakrishnan, Corey A. Siegel, Bryan G. Sauer & Millie D. Long. (2019) ACG Clinical Guideline: Ulcerative Colitis in Adults. American Journal of Gastroenterology 114:3, pages 384-413.
Crossref
Gordana Juricic, Tina Brencic, Andrea Tesija Kuna, Milena Njegovan & Lorena Honovic. (2019) Faecal calprotectin determination: impact of preanalytical sample treatment and stool consistency on within- and between-method variability. Biochemia medica 29:1, pages 112-122.
Crossref
N A Fadeeva, I A Korneeva, O V Knyazev & A I Parfenov. (2018) Biomarkers of inflammatory bowel disease activity. Terapevticheskii arkhiv 90:12, pages 107-111.
Crossref
Taojun He, Samuel E. Kaplan, Luz A. Gomez, Xuedong Lu, Lakshmi V. Ramanathan, Mini Kamboj & Yi-Wei Tang. (2018) Fecal calprotectin concentrations in cancer patients with Clostridium difficile infection. European Journal of Clinical Microbiology & Infectious Diseases 37:12, pages 2341-2346.
Crossref
Matthew J Brookes, Simon Whitehead, Daniel R Gaya & Antony Barney Hawthorne. (2018) Practical guidance on the use of faecal calprotectin. Frontline Gastroenterology 9:2, pages 87-91.
Crossref
Lillian Du, Rae Foshaug, Vivian W. Huang, Karen I. Kroeker, Levinus A. Dieleman, Brendan P. Halloran, Karen Wong & Richard N. Fedorak. (2018) Within-Stool and Within-Day Sample Variability of Fecal Calprotectin in Patients With Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 52:3, pages 235-240.
Crossref
Ruth M. Ayling & Klaartje Kok. 2018. 161 190 .
Matthijs Oyaert, Stefanie Van den Bremt, An Boel, Xavier Bossuyt & Lieve Van Hoovels. (2017) Do not forget about pre-analytics in faecal calprotectin measurement!. Clinica Chimica Acta 473, pages 124-126.
Crossref
Caroline Bello, Arne Roseth, Jordi Guardiola, Catherine Reenaers, Alexandra Ruiz-Cerulla, Catherine Van Kemseke, Claudia Arajol, Christian Reinhard, Laurence Seidel & Edouard Louis. (2017) Usability of a home-based test for the measurement of fecal calprotectin in asymptomatic IBD patients. Digestive and Liver Disease 49:9, pages 991-996.
Crossref
Vendel Kristensen, Arne Røseth, Tahir Ahmad, Viggo Skar & Bjørn Moum. (2017) Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis. Gastroenterology Research and Practice 2017, pages 1-5.
Crossref
Anke Heida, Alie Dijkstra, Sietske K. Dantuma & Patrick F. van Rheenen. (2016) A Cross-Sectional Study on the Perceptions and Practices of Teenagers With Inflammatory Bowel Disease About Repeated Stool Sampling. Journal of Adolescent Health 59:4, pages 479-481.
Crossref
Mary Hussey, Robert Mc Garrigle, Una Kennedy, Grainne Holleran, David Kevans, Barbara Ryan, Niall Breslin, Nasir Mahmud & Deirdre McNamara. (2016) Long-term assessment of clinical response to adalimumab therapy in refractory ulcerative colitis. European Journal of Gastroenterology & Hepatology 28:2, pages 217-221.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.